Testing the safety and effectiveness of the XEN63 gel implant for glaucoma
Part of Eyes & vision clinical trials.
This study tests a new gel implant (XEN63) to lower eye pressure in adults with open-angle glaucoma. It may be an option if your eye pressure remains high despite using eye drops, or if you can't tolerate the drops.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You should have open-angle glaucoma (not angle-closure).
- Your eye pressure is not well controlled with medications, or you cannot tolerate the side effects of eye drops.
- You have not had previous glaucoma filtering surgery like trabeculectomy or a drainage implant.
- You do not have active eye inflammation, infection, or certain other eye conditions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new implant that releases medicine for glaucoma while you have cataract surgery. It may help lower eye pressure without using daily drops.
This trial tests a tiny implant called MINIject S+ to lower eye pressure in people with open angle glaucoma that isn't well controlled with eye drops. It may be done alone or with cataract surgery.
This study compares two types of drainage implants (Baerveldt and Paul) to see which one works better at lowering eye pressure in people with glaucoma. If your glaucoma is not controlled with eye drops or other treatments, this trial may help find a more effective option.
This study looks at whether two types of tiny drainage stents (PreserFlo and XEN) work safely to lower eye pressure in glaucoma. Some patients will also receive an amniotic membrane (a thin tissue that helps healing) during the surgery, and researchers will compare outcomes.
This trial tests a sustained-release implant that delivers timolol, a medicine to lower eye pressure, for people with glaucoma or high eye pressure who are also having cataract surgery. The implant is placed during surgery and may provide long-term pressure control without daily eye drops.
This trial tests a small stent to help drain fluid from the eye and lower pressure in people who have both open-angle glaucoma and cataracts. The stent is placed during routine cataract surgery.
Hear when a new Glaucoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.